B

    Bio-Techne Corp (TECH)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $72.35
    -0.12 (-0.17%)

    Market Cap: $11.34B

    Last updated: Sep 01, 2026 at 5:00 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    80%(32/40)
    Avg Surprise
    +5.85%
    Streak
    10 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$0.44
    Range$0.42 - $0.47
    7 analysts
    EPS RevisionsNo revisions (7d)
    0
    1
    30d
    EPS Estimate Drift
    90d ago$0.44+0.0%
    60d ago$0.44-0.3%
    30d ago$0.44+0.4%
    7d ago$0.44+0.0%
    Current$0.44
    Revenue Consensus
    $292M
    Range$287M - $295M
    8 analysts
    Period ending Dec 31, 2026
    EPS Consensus$0.48
    Range$0.46 - $0.50
    3 analysts
    EPS RevisionsNo revisions (7d)
    0
    1
    30d
    EPS Estimate Drift
    90d ago$0.49+1.9%
    60d ago$0.49+1.8%
    30d ago$0.48+1.2%
    7d ago$0.48+1.2%
    Current$0.48
    Revenue Consensus
    $308M
    Range$303M - $313M
    8 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$0.48---
    Sep 26EST
    		-$0.44---
    Jun 26
    Reported Aug 5
    		$0.49$0.46+6.52%Beat-7.5%
    Mar 26
    Reported May 6
    		$0.53$0.53+0.00%Beat-5.4%
    Dec 25
    Reported Feb 4
    		$0.46$0.43+6.98%Beat+9.5%
    Sep 25
    Reported Nov 5
    		$0.36$0.36+0.00%Beat-14.3%
    Jun 25
    Reported Aug 6
    		$0.53$0.50+6.00%Beat+8.2%
    Mar 25
    Reported May 7
    		$0.56$0.51+9.80%Beat+16.7%
    Dec 24
    Reported Feb 5
    		$0.42$0.39+7.69%Beat+5.0%
    Sep 24
    Reported Oct 30
    		$0.42$0.38+10.53%Beat+2.4%
    Jun 24
    Reported Aug 7
    		$0.49$0.49+0.00%Beat-10.9%
    Mar 24
    Reported May 1
    		$0.48$0.46+4.35%Beat-9.4%
    Dec 23
    Reported Feb 1
    		$0.40$0.41-2.44%Miss-14.9%
    Sep 23
    Reported Oct 31
    		$0.41$0.44-6.82%Miss-8.9%
    Jun 23
    Reported Aug 8
    		$0.55$0.55+0.00%Beat+7.8%
    Mar 23
    Reported May 3
    		$0.53$0.53+0.00%Beat-1.9%
    Dec 22
    Reported Feb 2
    		$0.47$0.49-4.08%Miss+0.0%
    Sep 22
    Reported Nov 1
    		$0.45$0.46-2.17%Miss-2.2%
    Jun 22
    Reported Aug 4
    		$0.51$0.52-1.92%Miss+8.5%
    Mar 22
    Reported May 4
    		$0.54$0.50+8.00%Beat+20.0%
    Dec 21
    Reported Feb 1
    		$0.47$0.45+4.44%Beat+14.6%
    Sep 21
    Reported Nov 2
    		$0.46$0.43+6.98%Beat+27.8%
    Jun 21
    Reported Aug 5
    		$0.47$0.43+9.30%Beat+88.0%
    Mar 21
    Reported May 6
    		$0.45$0.39+15.38%Beat+28.6%
    Dec 20
    Reported Feb 2
    		$0.41$0.34+20.59%Beat+51.9%
    Sep 20
    Reported Nov 5
    		$0.36$0.28+28.57%Beat+33.3%
    Jun 20
    Reported Aug 4
    		$0.25$0.19+31.58%Beat-19.4%
    Mar 20
    Reported Apr 30
    		$0.35$0.28+25.00%Beat+16.7%
    Dec 19
    Reported Feb 4
    		$0.27$0.28-3.57%Miss+0.0%
    Sep 19
    Reported Oct 29
    		$0.27$0.26+3.85%Beat+8.0%
    Jun 19
    Reported Aug 6
    		$0.31$0.33-6.06%Miss-8.8%
    Mar 19
    Reported Apr 30
    		$0.30$0.29+3.45%Beat+0.0%
    Dec 18
    Reported Feb 5
    		$0.27$0.25+8.00%Beat+3.8%
    Sep 18
    Reported Oct 30
    		$0.25$0.24+4.17%Beat+8.7%
    Jun 18
    Reported Aug 7
    		$0.34$0.32+6.25%Beat+25.9%
    Mar 18
    Reported May 2
    		$0.30$0.29+3.45%Beat+25.0%
    Dec 17
    Reported Feb 6
    		$0.26$0.23+13.04%Beat+30.0%
    Sep 17
    Reported Oct 31
    		$0.23$0.22+4.55%Beat+9.5%
    Jun 17
    Reported Aug 8
    		$0.27$0.25+8.00%Beat-
    Mar 17
    Reported May 2
    		$0.24$0.23+4.35%Beat-
    Dec 16
    Reported Feb 7
    		$0.20$0.21-4.76%Miss-
    Sep 16
    Reported Oct 31
    		$0.21$0.20+5.00%Beat-

    Dividends

    Dividend Metrics

    Yield0.44%
    Annual/Share$0.32
    Payout Ratio17.13%
    Frequency4
    Pay MonthsFeb, May, Aug, Sep, Nov

    Growth

    3Y CAGR+0.00%
    5Y CAGR+0.00%
    View TECH's full dividend history

    Key Metrics

    Valuation
    P/E Ratio39.32EV/EBITDA32.76x
    Price/FCF42.97xFCF Yield2.33%
    Profitability
    Profit Margin15.00%Operating Margin27.90%
    ROE9.03%ROIC4.98%
    Financial Health
    Debt/Equity0.10xInterest Coverage25.55x
    Current Ratio4.49xQuick Ratio3.18x
    Trading Statistics
    Beta1.28Avg Volume2.87M
    52-Week High$72.5452-Week Low$43.02

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$72.32
    SMA 20$72.20
    SMA 50$70.53
    SMA 200$60.58
    EMA 10$72.31
    EMA 20$72.01
    EMA 50$68.96
    EMA 200$61.62

    MACD

    Line: 0.70Signal: 0.93Hist: -0.23

    ADX

    ADX: 57.1+DI: 27.8-DI: 8.4

    Aroon & PSAR

    Aroon Up64.0
    Aroon Down4.0
    PSAR$72.24

    Bollinger Bands

    Upper Band$72.55
    Lower Band$71.84
    %B Position97%(Upper)
    Band Width0.72

    RSI (14-Day)

    Neutral
    66.4

    Momentum Oscillators

    Stoch %K65.3
    Stoch %D65.3
    Williams %R-43.5
    ROC (10d)0.0%
    Momentum0.03
    CCI (20d)77.6
    MFI (14d)44.2

    Volatility Measures

    ATR (14d)$0.37(0.5%)
    StdDev (20d)0.18
    Hist Vol3.4%(Low)

    Volume Flow

    VWAP$72.38
    OBV103.6M
    AD Line-121.5M
    CMF (20d)-0.677

    Volume Metrics

    Avg Vol (20d)2.7M
    Vol Ratio0.6x
    VWMA (20d)$72.18

    Pivot Points

    R3$72.68
    R2$72.59
    R1$72.53
    Pivot Point$72.44
    S1$72.38
    S2$72.29
    S3$72.23

    Advanced Oscillators

    TSI39.68
    Ultimate Osc34.6
    KST10.48

    Financial Data

    QuarterMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023
    Total Revenue$311.42M$295.88M$286.56M$316.96M$316.18M$297.03M$289.46M$306.10M$303.43M$272.60M$276.94M$301.32M
    Cost of Revenue$103.13M$104.60M$98.44M$118.15M$101.63M$103.14M$106.44M$102.75M$98.83M$96.01M$91.74M$96.62M
    Gross Profit$208.29M$191.28M$188.11M$198.81M$214.56M$193.89M$183.02M$203.35M$204.60M$176.59M$185.19M$204.70M
    Operating Expenses$132.79M$136.82M$140.45M$222.67M$175.85M$146.47M$143.03M$157.53M$137.60M$138.58M$129.33M$110.17M
    R&D$23.45M$23.13M$24.24M$26.03M$24.58M$25.02M$23.87M$23.99M$25.76M$22.92M$24.00M$23.42M
    SG&A$109.34M$113.69M$116.21M$196.64M$151.27M$121.45M$119.16M$133.54M$111.84M$115.67M$105.33M$86.75M
    Operating Income$75.50M$54.46M$47.66M$-23,859,000$38.71M$47.42M$39.99M$45.82M$67.00M$38.00M$55.86M$94.53M
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$4.27M$3.68M$0$0$434,000$4.54M$0$4.16M$5.91M$4.62M$6.30M$6.21M
    Income Before Tax$71.22M$50.78M$47.99M$-22,858,000$38.27M$42.88M$40.17M$41.66M$61.08M$33.39M$49.56M$88.32M
    Income Tax Expense$20.18M$12.78M$9.81M$-5,180,000$15.69M$7.99M$6.57M$1.07M$12.03M$5.92M$-1,435,000$12.83M
    Net Income$51.05M$38.01M$38.19M$-17,678,000$22.59M$34.89M$33.60M$40.59M$49.06M$27.46M$50.99M$75.48M
    EBITDA$99.66M$79.17M$72.00M$3.25M$66.28M$74.50M$68.12M$73.88M$94.31M$61.19M$78.10M$121.45M
    EBIT$75.50M$54.46M$47.66M$-23,859,000$38.71M$47.42M$39.99M$45.82M$67.00M$33.39M$49.56M$94.53M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about TECH

    News

    Research Tools & Consumables Stocks Q2 Highlights: Bruker (NASDAQ:BRKR)

    The article reviews the Q2 performance of several research tools and consumables stocks, highlighting Bruker (NASDAQ:BRKR) as having the weakest performance relative to analyst estimates and full-year guidance. In contrast, Avantor (NYSE:AVTR) achieved the best Q2 results with significant analyst estimate beats. Other companies like Waters Corporation (NYSE:WAT), Bio-Techne (NASDAQ:TECH), and Danaher (NYSE:DHR) also had varying Q2 outcomes.

    Yahoo! Finance Canada•9/1/26•
    Somewhat-Bullish

    Legal & General buys $19.51M stake in Bio-Techne

    Legal & General Group Plc has acquired a new stake worth $19.51 million in Bio-Techne Corp, a biotechnology company providing tools and reagents for life sciences. This investment gives Legal & General a 0.18% stake in Bio-Techne, which recently reported strong earnings and revenue, increased its quarterly dividend significantly, and has seen institutional ownership rise to 98.95%. Analyst views are mixed despite the company's strong performance and share price near a 12-month high.

    Dealroom•8/30/26•
    Somewhat-Bullish

    Trading Systems Reacting to (TECH) Volatility

    Bio-techne Corp (NASDAQ: TECH) is currently exhibiting neutral sentiment across all time horizons, suggesting a wait-and-see approach for investors. AI models have generated distinct trading strategies including position trading, momentum breakout, and risk hedging, with specific entry, target, and stop-loss levels. The analysis indicates compelling upside potential as no resistance levels remain above the current price.

    Stock Traders Daily•8/29/26•
    Neutral

    Bio-Techne (TECH) Stock Could Be 26% Overvalued On Growth Hopes

    Bio-Techne's stock appears to be overvalued by approximately 26% based on Discounted Cash Flow (DCF) analysis and its P/E ratio of 62.4x, which is significantly higher than the industry average. Despite a recent rebound, the company has seen a 40.3% decline over the past five years, raising concerns about its current premium valuation relative to its intrinsic value and industry peers. Investors are advised to consider whether future revenue and margin growth can justify the current price.

    Webull•8/25/26•
    Bearish

    BIO-TECHNE Corp FY 2026: Revenue $1.22B, EPS $1.16— 10-K Summary

    BIO-TECHNE Corp reported flat consolidated net sales of $1.22 billion for fiscal year 2026, while net income significantly increased to $181.86 million, with diluted EPS rising to $1.16. Revenue growth was flat organically, offset by foreign exchange gains and divestitures, and the company completed an acquisition and announced a pending cash merger.

    TradingView•8/24/26•
    Bullish

    Frequently Asked Questions About TECH

    What is TECH's current dividend yield?
    Bio-Techne Corp (TECH) has a current dividend yield of 0.44%.
    Does TECH pay dividends?
    Yes, Bio-Techne Corp pays dividends with a current yield of 0.44%.
    What is TECH's P/E ratio?
    Bio-Techne Corp has a price-to-earnings (P/E) ratio of 39.32.
    What is TECH's market cap?
    Bio-Techne Corp (TECH) has a market capitalization of $11.34B with a current stock price of $72.35.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In